Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M.
Journal Article 2009; 30(1): 107-110 PubMed PMID: 19300395 Keywords: Acromegaly:etiology, Adenoma:complications, Adrenocorticotropic Hormone:secretion, Adult, Aged, Cell Proliferation:drug effects, Cell Survival:drug effects, Drug Evaluation, Preclinical, Female, Human Growth Hormone:secretion, Humans, Hypoglycemic Agents:. CitationOBJECTIVES: Rosiglitazone (RGZ) belongs to thiazolidinediones - new class of antidiabetic drugs which are PPARgamma agonists. It was shown.....
Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro. Neuro Endocrinol Lett. 2009 Mar; 30(1): 107-110
Gruszka A, Kunert-Radek J, Pawlikowski M.
Journal Article 2005; 26(1): 51-54 PubMed PMID: 15726020 Keywords: Animals, Carcinogens:administration & dosage, Cell Survival:drug effects, Diethylstilbestrol:administration & dosage, Drug Implants, Hypoglycemic Agents:pharmacology, Ligands, Male, PPAR gamma:drug effects, Pituitary Neoplasms:chemically induced, Prolacti. CitationOBJECTIVES: PPAR-gamma is a member of the nuclear receptor superfamily. PPAR-gamma activation is associated with glucose metabolism regula.....
Gruszka A, Kunert-Radek J, Pawlikowski M. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro. Neuro Endocrinol Lett. 2005 Feb; 26(1): 51-54
Gruszka A, Pawlikowski M, Kunert-Radek J.
Journal Article 2001; 22(5): 343-348 PubMed PMID: 11600876 Keywords: Animals, Antineoplastic Agents:therapeutic use, Apoptosis:drug effects, Bromocriptine:therapeutic use, Cell Division:drug effects, DNA Fragmentation, Diethylstilbestrol:administration & dosage, Drug Implants, In Situ Nick-End Labeling, Male, Octreotide:th. CitationOBJECTIVES: The purpose of the study was to compare the effects of bromocriptine (BC) - D-2 receptor agonist and octreotide (OCT) - somato.....
Gruszka A, Pawlikowski M, Kunert-Radek J. Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects. Neuro Endocrinol Lett. 2001 Oct; 22(5): 343-348